Grazoprevir/elbasvir combination therapy for HCV infection
Interferon-free regimens combine different second-wave direct-acting antiviral agents (DAAs), which target the main viral proteins involved in the replication cycle of hepatitis C virus (HCV): NS3/4A protease inhibitors (simeprevir or paritaprevir boosted by ritonavir), NS5B nucleos(t)idic (sofosbuv...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publishing
2017-01-01
|
| Serija: | Therapeutic Advances in Gastroenterology |
| Online pristup: | https://doi.org/10.1177/1756283X16671293 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|